MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Janux Therapeutics, Inc. Common Stock

JANX

#2189
Janux Therapeutics, Inc. Common Stock
13.61
+0.59%
Sector:
Básica:
Profit Currency:
Rango diario
13.61
13.61
Rango anual
12.12
35.25
Cambio diario
+0.59%
Monthly Change
-7.60%
6 month change
-42.31%
Cambio anual
-57.99%
Cierres anteriores
13.53
Open
13.61
Bid
Ask
Low
13.61
High
13.61
Volumen
116
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. JANX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20212022202320242025 TTM

Noticias

Investing Investing
JANX
2026.02.17
Janux therapeutics doses first participant in JANX011 phase 1 trial
Seeking Alpha Seeking Alpha
VIR JANX
2026.02.06
Vir Biotechnology Stock: The Low-Down On The Readouts Ahead (NASDAQ:VIR)
Zacks Zacks
JANX
2026.02.03
Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?
Investing Investing
JANX
2026.01.26
Janux Therapeutics nombra a William Go como nuevo director médico
Investing Investing
JANX
2026.01.26
Janux Therapeutics nombra a William Go como nuevo director médico
Investing Investing
JANX
2026.01.26
Janux Therapeutics appoints William Go as new chief medical officer
Seeking Alpha Seeking Alpha
BMY JANX
2026.01.23
Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion (BMY)
Zacks Zacks
BMY FOLD KROS JANX
2026.01.23
JANX Enters Global Oncology Collaboration With BMY, Stock Rises
Investing Investing
BMY JANX
2026.01.22
Las acciones de Janux suben tras acuerdo de colaboración con Bristol Myers Squibb
Investing Investing
BMY JANX
2026.01.22
Acciones de Janux suben tras acuerdo de colaboración con Bristol Myers Squibb
Investing Investing
BMY JANX
2026.01.22
Janux stock rises after Bristol Myers Squibb collaboration deal
Benzinga Benzinga
JANX BMY MRK
2026.01.22
Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million - Janux Therapeutics (NASDAQ:JANX)

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd